SurGenTec Gains 510(k) for TiLink-L SI Joint Fusion

SurGenTec TiLink-L Sacroiliac Joint Fusion

SurGenTec was granted FDA 510(k) clearance to market their proprietary TiLink-L Sacroiliac Joint Fusion System. The device may be implanted from a lateral or posterior/oblique approach and uses unique surface technology to optimize bone growth. This implant will be SurGenTec’s inaugural “First Implant in the Sacroiliac Family of Products.”

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us